Published in Kidney Int on May 28, 2008
Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) (2010) 2.99
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol (2010) 2.24
Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol (2011) 2.04
Autophagy in proximal tubules protects against acute kidney injury. Kidney Int (2012) 1.98
Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol (2010) 1.93
The cell cycle and acute kidney injury. Kidney Int (2009) 1.81
Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol (2009) 1.74
AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J Cell Mol Med (2009) 1.67
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J Am Soc Nephrol (2010) 1.45
Autophagy promotes intracellular degradation of type I collagen induced by transforming growth factor (TGF)-β1. J Biol Chem (2012) 1.45
Emerging role of autophagy in kidney function, diseases and aging. Autophagy (2012) 1.43
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene (2011) 1.32
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med (2010) 1.25
Glutamine increases autophagy under Basal and stressed conditions in intestinal epithelial cells. Gastroenterology (2008) 1.23
Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am J Physiol Renal Physiol (2009) 1.22
Augmenting autophagy to treat acute kidney injury during endotoxemia in mice. PLoS One (2013) 1.21
BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response. EMBO J (2011) 1.21
Nutrient sensing, autophagy, and diabetic nephropathy. Diabetes (2012) 1.19
Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int (2014) 1.18
TGF-{beta}1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem (2010) 1.17
Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res (2011) 1.14
zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function. Am J Physiol Renal Physiol (2012) 1.12
The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Mol Biol Cell (2011) 1.02
Autophagy as a therapeutic target in diabetic nephropathy. Exp Diabetes Res (2011) 1.02
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol (2014) 1.02
Macroautophagy: a mechanism for mediating cell death or for promoting cell survival? Kidney Int (2008) 1.01
Autophagy in acute kidney injury. Semin Nephrol (2013) 0.98
Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease. FEBS Lett (2012) 0.95
The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res (2013) 0.94
Mitochondrial dysregulation and protection in cisplatin nephrotoxicity. Arch Toxicol (2014) 0.93
Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. J Am Soc Nephrol (2014) 0.92
The aging kidney: increased susceptibility to nephrotoxicity. Int J Mol Sci (2014) 0.92
Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol (2011) 0.92
Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin. Biochem Pharmacol (2013) 0.91
The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation. Am J Pathol (2009) 0.90
Autophagy in kidney health and disease. Antioxid Redox Signal (2013) 0.90
Autophagy in acute kidney injury. Kidney Int (2016) 0.88
Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Lab Invest (2014) 0.88
Mitochondrial function and disturbances in the septic kidney. Semin Nephrol (2015) 0.88
Targeting protective autophagy exacerbates UV-triggered apoptotic cell death. Int J Mol Sci (2012) 0.88
Autophagic clearance of mitochondria in the kidney copes with metabolic acidosis. J Am Soc Nephrol (2014) 0.88
Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy. Biomed Res Int (2014) 0.87
Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clin Kidney J (2015) 0.87
APOL1 toxin, innate immunity, and kidney injury. Kidney Int (2015) 0.86
Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction. Sci Rep (2016) 0.85
Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction. Autophagy (2016) 0.84
Autophagy activation reduces renal tubular injury induced by urinary proteins. Autophagy (2013) 0.84
The Role of Autophagy in Kidney Inflammatory Injury via the NF-κB Route Induced by LPS. Int J Med Sci (2015) 0.83
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib. Sci Rep (2014) 0.83
Cellular and Molecular Mechanisms of AKI. J Am Soc Nephrol (2016) 0.83
Heme Oxygenase-1 in Kidney Health and Disease. Antioxid Redox Signal (2016) 0.82
αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy. J Am Soc Nephrol (2015) 0.82
Autophagy is activated to protect against endotoxic acute kidney injury. Sci Rep (2016) 0.81
Autophagy in acute kidney injury and repair. Nephron Clin Pract (2014) 0.81
Autophagy: a protective mechanism against nephrotoxicant-induced renal injury. Kidney Int (2009) 0.81
Reduced expression of lipoic acid synthase accelerates diabetic nephropathy. J Am Soc Nephrol (2011) 0.81
Dynamic Modeling of the Interaction Between Autophagy and Apoptosis in Mammalian Cells. CPT Pharmacometrics Syst Pharmacol (2015) 0.81
Autophagy: a novel therapeutic target for kidney diseases. Clin Exp Nephrol (2012) 0.80
Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity. J Am Soc Nephrol (2016) 0.79
Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy. Acta Pharmacol Sin (2016) 0.79
Autophagy protects against necrotic renal epithelial cell-induced death of renal interstitial fibroblasts. Am J Physiol Renal Physiol (2012) 0.79
DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol (2015) 0.78
Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI. J Nephrol (2015) 0.78
Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines. Oncotarget (2015) 0.78
Autophagy and Tubular Cell Death in the Kidney. Semin Nephrol (2016) 0.77
Overexpression of p18INK⁴C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis. Pediatr Nephrol (2011) 0.77
Sirtuin 1: A Target for Kidney Diseases. Mol Med (2015) 0.77
Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro. Int J Mol Med (2015) 0.76
Autophagy regulates colistin-induced apoptosis in PC-12 cells. Antimicrob Agents Chemother (2015) 0.76
Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy. Clin Exp Nephrol (2013) 0.76
Autophagy inhibits cell death induced by the anti-cancer drug morusin. Am J Cancer Res (2017) 0.75
Self-eating for death or survival during cisplatin nephrotoxicity? Clin Exp Nephrol (2010) 0.75
HO-1 in control of a self-eating kidney. J Am Soc Nephrol (2010) 0.75
Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy. Int J Clin Exp Pathol (2014) 0.75
Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression. PLoS One (2017) 0.75
Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Res Ther (2017) 0.75
Enhanced Autophagy in Polycystic Kidneys of AQP11 Null Mice. Int J Mol Sci (2016) 0.75
Heat shock factor 1 induces crystallin-αB to protect against cisplatin nephrotoxicity. Am J Physiol Renal Physiol (2016) 0.75
Unique sex- and age-dependent effects in protective pathways in acute kidney injury. Am J Physiol Renal Physiol (2017) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res (2011) 5.40
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet (2004) 4.95
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol (2007) 4.45
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem (2006) 3.74
Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology (2010) 3.57
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest (2009) 3.53
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol (2003) 3.51
Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem (2010) 2.93
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell (2011) 2.83
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81
Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc Natl Acad Sci U S A (2007) 2.65
Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy (2007) 2.59
The structural basis of blebbistatin inhibition and specificity for myosin II. Nat Struct Mol Biol (2005) 2.45
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction (2007) 2.38
ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem (2007) 2.31
Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol (2010) 2.24
Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci (2007) 2.23
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J Hepatol (2013) 2.14
Dissecting the dynamic turnover of GFP-LC3 in the autolysosome. Autophagy (2011) 2.11
Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem (2002) 2.10
The impact of prevention on reducing the burden of cardiovascular disease. Circulation (2008) 2.05
Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood (2010) 2.03
Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res (2011) 1.99
Autophagy in proximal tubules protects against acute kidney injury. Kidney Int (2012) 1.98
Novel algorithms and the benefits of comparative validation. Bioinformatics (2013) 1.97
Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem (2012) 1.95
HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol (2012) 1.92
New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA (2011) 1.88
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J Biol Chem (2008) 1.84
Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.82
Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81
Prospective evaluation of the sensitivity of physical examination in chest trauma. J Trauma (2002) 1.80
Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes. Hepatology (2004) 1.79
Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem (2004) 1.79
Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proc Natl Acad Sci U S A (2009) 1.75
Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation (2011) 1.74
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res (2009) 1.74
Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci (2004) 1.73
Electrical coupling between mammalian cones. Curr Biol (2002) 1.72
Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol (2007) 1.70
Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med (2004) 1.69
Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy. Mol Cancer Ther (2009) 1.69
PKC-delta promotes renal tubular cell apoptosis associated with proteinuria. J Am Soc Nephrol (2010) 1.67
To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol (2003) 1.66
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
Membrane potential-dependent modulation of recurrent inhibition in rat neocortex. PLoS Biol (2011) 1.58
The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am J Physiol Renal Physiol (2009) 1.56
Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab (2005) 1.55
Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proc Natl Acad Sci U S A (2011) 1.54
Combining biomarkers to detect disease with application to prostate cancer. Biostatistics (2003) 1.54
Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev (2003) 1.53
Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin (2004) 1.52
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol (2013) 1.52
microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol (2011) 1.50
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol (2004) 1.49
Induction of macroautophagy by exogenously introduced calcium. Autophagy (2008) 1.48
Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int (2013) 1.46
A system-wide intervention to improve HIV testing in the Veterans Health Administration. J Gen Intern Med (2008) 1.46
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. J Exp Med (2011) 1.45
Automating arm movement training following severe stroke: functional exercises with quantitative feedback in a gravity-reduced environment. IEEE Trans Neural Syst Rehabil Eng (2006) 1.44
Emerging role of autophagy in kidney function, diseases and aging. Autophagy (2012) 1.43
Biochemical isolation and characterization of the tubulovesicular LC3-positive autophagosomal compartment. J Biol Chem (2009) 1.41
Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report. J Med Case Rep (2008) 1.41
Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem (2003) 1.39
Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res (2010) 1.39
Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharmacol Exp Ther (2008) 1.38
Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol Biol Cell (2004) 1.38
Mouse model of ischemic acute kidney injury: technical notes and tricks. Am J Physiol Renal Physiol (2012) 1.36
Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. Am J Physiol Cell Physiol (2010) 1.36
Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem (2013) 1.35
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. J Clin Invest (2011) 1.35
Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion. Circ Res (2006) 1.33
Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem (2010) 1.32
Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem (2006) 1.30
Adhesion/cementation to zirconia and other non-silicate ceramics: where are we now? Dent Mater (2010) 1.26
A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells. Mol Cancer Ther (2007) 1.26
The impact of prevention on reducing the burden of cardiovascular disease. Diabetes Care (2008) 1.25
Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem (2012) 1.25
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med (2010) 1.25
Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events. J Biol Chem (2004) 1.23
Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am J Physiol Renal Physiol (2009) 1.22
hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. J Biol Chem (2011) 1.21
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res (2008) 1.21
Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem (2007) 1.21